Follow the Biosino Bio-Technology and Science Incorporation - H Shares share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Market capitalisation: €286.5m. The latest transaction was disclosed on 15 July 2026 (Purchase). Among the most active insiders: Kang Rui. Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€1m
10 ops.
Buy Volume
n/a
n/a
Sell Volume
17Σ signal
Buys €1mn/a Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,773 of 26,550 companies
18.1
score / 100
Value
13
Quality
23
FCF yld-11%
Earn yld-18%
EV/EBITDA·
ROE-45%
Gross mgn38%
Net mgn-28%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2,000 shares@ HK$3.485.8% of flowShareXHKGHKEX:DA20260601E00019
Canonical exit: 12 Apr 2026 (T+90)
10 of 10 declarations
About Biosino Bio-Technology and Science Incorporation - H Shares
Biosino Bio-Technology and Science Incorporation - H Shares is a company specializing in biotechnology and life sciences. It focuses on the development and commercialization of innovative products and services in the healthcare sector.